Simplifying Global Compliance
FDA Hopes Artificial Pancreas Guidance is Flexible, Encouraging
Devices & Diagnostics Letter
The FDA intends a new draft guidance on development of artificial pancreas device systems to be a map rather than a roadblock, an FDA official said in a Dec. 1 briefing.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing